SAVA 241122 33.50P (SAVA241122P33500) Stock Options, News & Quotes

US OptionsDetailed Quotes

SAVA241122P33500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 21 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Express News | Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
ReutersNov 18 08:30 ET
Press Release: Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
Dow JonesNov 18 08:30 ET
Cassava Sciences Updates on Phase 3 Alzheimer's Trial Ahead of Key Readout
Seeking AlphaNov 15 11:17 ET
Cassava Sciences' Simufilam 100 Mg For Mild-To-Moderate Alzheimer's Disease (RETHINK-ALZ) Posted On ClinicalTrials Website On November 15, 2024
BenzingaNov 15 10:51 ET
Cassava Sciences Analyst Ratings
BenzingaNov 8 14:27 ET · Ratings
H.C. Wainwright Maintains Cassava Sciences(SAVA.US) With Buy Rating, Maintains Target Price $116
Moomoo NewsNov 8 07:35 ET · Ratings

Comments

JAYYFLASH

10 hours ago

$Cassava Sciences (SAVA.US)$SAVA still trading up now past after hours

JAYYFLASH

15 hours ago

$Cassava Sciences (SAVA.US)$ New Form 4 by Clinical Dev Officer. All the way Bullish

JAYYFLASH

19 hours ago

$Cassava Sciences (SAVA.US)$ We do need Someone better at SEC that will actually hold the naked shorting accountable. SAVA bullish

Night Pig

Yesterday 06:57

Another big move!

$Cassava Sciences (SAVA.US)$
I feel that Cassava management team must be feeling extremely confident of an approval with the recent additions! I don't see a way to spin this in a negative way for the shorts

JAYYFLASH

Yesterday 02:52

$Cassava Sciences (SAVA.US)$ 30k shares at $26.60 and 30k shares at $26.63. Someone i
s shorting to load up shares at a lower price. Market manipulators getting in at lower price for when the stock price rises up soon